Singapore markets closed

Myomo, Inc. (MYO)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
3.9300+0.3100 (+8.56%)
At close: 04:00PM EDT
3.6500 -0.28 (-7.12%)
After hours: 07:47PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.6200
Open3.6300
Bid3.2900 x 800
Ask4.2700 x 1300
Day's range3.5200 - 3.9650
52-week range0.3710 - 5.5800
Volume353,587
Avg. volume281,406
Market cap113.182M
Beta (5Y monthly)1.50
PE ratio (TTM)N/A
EPS (TTM)-0.2800
Earnings date07 Aug 2024 - 12 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est5.50
  • Business Wire

    Myomo Reports First Quarter 2024 Financial Results

    BOSTON, May 08, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2024.

  • Business Wire

    Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees

    BOSTON, May 06, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Centers for Medicare & Medicaid Services ("CMS"), through their regional contractors known as the DME MACs, have remitted and paid lump sum reimbursements to the Company and are beginning to reimburse orthotics and prosthetics ("O&P") providers f

  • Business Wire

    Myomo to Report First Quarter Financial Results on May 8, 2024

    BOSTON, May 01, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2024 on May 8, 2024.